Wearable Patches market is set to experience significant growth, with projections indicating an increase from USD 10.25 billion in 2024 VANCOUVER, BRITISH COLUMBIA ...

The much-delayed, riding-on-controversies ‘Emergency’, written and directed by Kangana Ranaut, is finally out. The long disclaimer states that the biographical feature ‘draws information from the life ...

“India is Indira and Indira is India.” It was a pleasure getting to know the true Indira Gandhi through the lens of Kangana Ranaut. She effortlessly fitted into the role with her facial expressions ...

WASHINGTON (AP) — When thousands of National Guard forces and law enforcement officers locked down Washington during racial protests and the Jan. 6 riot four years ago, the blur of camouflage ...

Kangana Ranaut’s much-anticipated political drama Emergency has had a sluggish start at the box office, according to early estimates. The film which is finally releasing in theatres after months ...

What’s Good: No political vested interest but a balanced yet incisive look at India’s most controversial prime minister. What’s Bad: An episodic feeling in parts. Though the film is titled ...

Emergency movie review: Fine acting performances, led by Kangana Ranaut, salvage this film, but only barely, as a week script lets it down. Emergency movie review: Kangana Ranaut plays former PM ...

Kangana Ranaut’s Emergency is a rare film that doesn’t just entertain—it provokes, challenges, and forces us to reflect on the nature of governance and the personal costs of political leadership.

Kangana Ranaut’s Emergency marks a bold and ambitious foray into filmmaking, offering a gripping, multifaceted exploration of one of the most controversial periods in modern Indian history.

Quick take: Emergency portrays Indira Gandhi as an iron lady who uplifted India through her rule. Kangana Ranaut has directed the film and essayed the lead role. The film starts with a speech by ...

CD Formulation, a contract research and development biotech firm, has designed patch tests for evaluating risky skin reactions. NY, UNITED STATES, January 17, 2025 ...